119 related articles for article (PubMed ID: 11073715)
1. Genetic basis of hyperhomocysteinemia.
Medina MA; Amores-Sánchez MI
Mol Genet Metab; 2000 Nov; 71(3):478-80. PubMed ID: 11073715
[No Abstract] [Full Text] [Related]
2. Homocysteine and ischaemic heart disease.
Law MR; Wald NJ
Haematologica; 1999 Jun; 84 Suppl EHA-4():57-60. PubMed ID: 10907469
[No Abstract] [Full Text] [Related]
3. Homocysteine, folate enzymes and neural tube defects.
Molloy AM; Weir DG; Scott JM
Haematologica; 1999 Jun; 84 Suppl EHA-4():53-6. PubMed ID: 10907468
[No Abstract] [Full Text] [Related]
4. Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension.
Garfunkel VA; Porto PI; Garcia SI; Dieuzeide G; Kirszner T; Plotquin Y; Spataro RJ; Gonzalez C; Pirola CJ
J Hum Hypertens; 2003 May; 17(5):361-4. PubMed ID: 12756410
[No Abstract] [Full Text] [Related]
5. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of homocysteine metabolism.
Födinger M; Buchmayer H; Sunder-Plassmann G
Miner Electrolyte Metab; 1999; 25(4-6):269-78. PubMed ID: 10681651
[TBL] [Abstract][Full Text] [Related]
7. [Correlation analysis between plasma homocysteine level and polymorphism of homocysteine metabolism related enzymes in ischemic cerebrovascular or cardiovascular diseases].
Zhang G; Dai C
Zhonghua Xue Ye Xue Za Zhi; 2002 Mar; 23(3):126-9. PubMed ID: 12015064
[TBL] [Abstract][Full Text] [Related]
8. [Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].
Spiridonova MG; Stepanov VA; Puzyrev VP
Klin Med (Mosk); 2001; 79(2):10-6. PubMed ID: 11419077
[No Abstract] [Full Text] [Related]
9. Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism.
Gos M; Szpecht-Potocka A
J Appl Genet; 2002; 43(4):511-24. PubMed ID: 12441636
[TBL] [Abstract][Full Text] [Related]
10. [Genetic polymorphisms of homocysteine metabolism related enzymes in patients with coronary heart disease].
Xu H; Chen Z; Tang J
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):414-6. PubMed ID: 11715433
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia and C677T mutation of methylenetetrahydrofolate reductase].
Grasa Ullrich JM; Torres Gómez M; Sánchez Marín B; Calvo Martín MT; García Erce JA; Giralt Raichs M
An Med Interna; 2002 May; 19(5):269. PubMed ID: 12108010
[No Abstract] [Full Text] [Related]
12. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases.
Tsai MY; Welge BG; Hanson NQ; Bignell MK; Vessey J; Schwichtenberg K; Yang F; Bullemer FE; Rasmussen R; Graham KJ
Atherosclerosis; 1999 Mar; 143(1):163-70. PubMed ID: 10208491
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.
Pathare A; al Kindi S; al Belushi T; Bayoumi R; Dennison D; Murlitharan S
Haematologia (Budap); 2002; 32(4):551-6. PubMed ID: 12803132
[TBL] [Abstract][Full Text] [Related]
14. How folate fights disease.
Nat Struct Biol; 1999 Apr; 6(4):293-4. PubMed ID: 10201387
[No Abstract] [Full Text] [Related]
15. Spina bifida and common mutations at the homocysteine metabolism pathway.
Akar N; Akar E; Deda G; Arsan S
Clin Genet; 2000 Mar; 57(3):230-1. PubMed ID: 10782931
[No Abstract] [Full Text] [Related]
16. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
Paz MF; Avila S; Fraga MF; Pollan M; Capella G; Peinado MA; Sanchez-Cespedes M; Herman JG; Esteller M
Cancer Res; 2002 Aug; 62(15):4519-24. PubMed ID: 12154064
[TBL] [Abstract][Full Text] [Related]
17. [Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population].
Belkahla R; Omezzine A; Kchok K; Rebhi L; Ben Hadj Mbarek I; Rejeb J; Ben Rejeb N; Slimane N; Nabli N; Ben Abdelaziz A; Boughzala E; Bouslama A
Ann Cardiol Angeiol (Paris); 2008 Aug; 57(4):219-24. PubMed ID: 18620331
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia: another independent vascular risk factor.
Deleu D
Saudi Med J; 2000 Aug; 21(8):787-8. PubMed ID: 11423902
[No Abstract] [Full Text] [Related]
19. Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men.
Dekou V; Gudnason V; Hawe E; Miller GJ; Stansbie D; Humphries SE
Thromb Haemost; 2001 Jan; 85(1):67-74. PubMed ID: 11204591
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation of the methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and a new polymorphism in intron 7.
Hong SH; Song J; Kim JQ
Mol Cell Probes; 2001 Apr; 15(2):119-23. PubMed ID: 11292330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
